5e13
From Proteopedia
(Difference between revisions)
m (Protected "5e13" [edit=sysop:move=sysop]) |
|||
(2 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of Eosinophil-derived neurotoxin in complex with the triazole double-headed ribonucleoside 11c== | |
+ | <StructureSection load='5e13' size='340' side='right'caption='[[5e13]], [[Resolution|resolution]] 1.34Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[5e13]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5E13 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5E13 FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.34Å</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5J9:3-{4-[(4-AMINO-2-OXOPYRIMIDIN-1(2H)-YL)METHYL]-1H-1,2,3-TRIAZOL-1-YL}-3-DEOXYADENOSINE'>5J9</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5e13 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5e13 OCA], [https://pdbe.org/5e13 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5e13 RCSB], [https://www.ebi.ac.uk/pdbsum/5e13 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5e13 ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/RNAS2_HUMAN RNAS2_HUMAN] This is a non-secretory ribonuclease. It is a pyrimidine specific nuclease with a slight preference for U. Cytotoxin and helminthotoxin. Selectively chemotactic for dendritic cells. Possesses a wide variety of biological activities.<ref>PMID:3458170</ref> <ref>PMID:12578357</ref> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Eosinophil derived neurotoxin (EDN) is an eosinophil secretion protein and a member of the Ribonuclease A (RNase A) superfamily involved in the immune response system and inflammatory disorders. The pathological actions of EDN are strongly dependent on the enzymatic activity and therefore, it is of significant interest to discover potent and specific inhibitors of EDN. In this framework we have assessed the inhibitory potency of triazole double-headed ribonucleosides. We present here an efficient method for the heterologous production and purification of EDN together with the synthesis of nucleosides and their biochemical evaluation in RNase A and EDN. Two groups of double-headed nucleosides were synthesized by the attachment of a purine or a pyrimidine base, through a triazole group at the 3'-C position of a pyrimidine or a purine ribonucleoside, respectively. Based on previous data with mononucleosides these compounds were expected to improve the inhibitory potency for RNase A and specificity for EDN. Kinetics data revealed that despite the rational, all but one, double-headed ribonucleosides were less potent than the respective mononucleosides while they were also more specific for ribonuclease A than for EDN. Compound 11c (9-[3'-[4-[(cytosine-1-yl)methyl]-1,2,3-triazol-1-yl]-beta-d-ribofuranosyl]adenin e) displayed a stronger preference for EDN than for ribonuclease A and a Ki value of 58muM. This is the first time that an inhibitor is reported to have a better potency for EDN than for RNase A. The crystal structure of EDN-11c complex reveals the structural basis of its potency and selectivity providing important guidelines for future structure-based inhibitor design efforts. | ||
- | + | Triazole double-headed ribonucleosides as inhibitors of eosinophil derived neurotoxin.,Chatzileontiadou DS, Parmenopoulou V, Manta S, Kantsadi AL, Kylindri P, Griniezaki M, Kontopoulou F, Telopoulou A, Prokova H, Panagopoulos D, Boix E, Balatsos NA, Komiotis D, Leonidas DD Bioorg Chem. 2015 Dec;63:152-65. doi: 10.1016/j.bioorg.2015.10.007. Epub 2015 Oct, 31. PMID:26551065<ref>PMID:26551065</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[Category: | + | </div> |
- | [[Category: | + | <div class="pdbe-citations 5e13" style="background-color:#fffaf0;"></div> |
- | [[Category: Chatzileontiadou | + | == References == |
- | [[Category: Leonidas | + | <references/> |
- | [[Category: Stravodimos | + | __TOC__ |
+ | </StructureSection> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Chatzileontiadou DSM]] | ||
+ | [[Category: Kantsadi AL]] | ||
+ | [[Category: Leonidas DD]] | ||
+ | [[Category: Stravodimos GA]] |
Current revision
Crystal structure of Eosinophil-derived neurotoxin in complex with the triazole double-headed ribonucleoside 11c
|